Page last updated: 2024-10-19

melatonin and Precursor Cell Lymphoblastic Leukemia-Lymphoma

melatonin has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 2 studies

Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

Research Excerpts

ExcerptRelevanceReference
"With the improvement in children's acute lymphoblastic leukemia (ALL) care, the survival rate in children ALL has improved much."1.91Melatonin protects against methotrexate hepatotoxicity in young rats: Impact of PI3K/Akt/mTOR signaling. ( Chen, YC; Hsiao, CC; Hsieh, HY; Huang, LT; Huang, YC; Lo, WS; Sheen, JM; Wang, SC, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Wang, SC1
Huang, YC1
Hsiao, CC1
Sheen, JM1
Huang, LT1
Lo, WS1
Hsieh, HY1
Chen, YC1
Zhelev, Z1
Ivanova, D1
Bakalova, R1
Aoki, I1
Higashi, T1

Other Studies

2 other studies available for melatonin and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Melatonin protects against methotrexate hepatotoxicity in young rats: Impact of PI3K/Akt/mTOR signaling.
    Journal of biochemical and molecular toxicology, 2023, Volume: 37, Issue:5

    Topics: Animals; Chemical and Drug Induced Liver Injury; Melatonin; Methotrexate; Phosphatidylinositol 3-Kin

2023
Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes But Not Normal Lymphocytes.
    Anticancer research, 2017, Volume: 37, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Survival; Dos

2017